Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPCN 1154A in postpartum depression
NCT06979544Phase 3Completed
- Sponsor
- Lipocine Inc
- Start
- Jun 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of BRLIZIO in postpartum depression (PPD), sponsored by Lipocine Inc. Started Jun 2025; status: completed.
02
Drugs
BRLIZIO
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT06979544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06979544.